Carolina Garrido
Carolina Garrido
aUNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
bDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
a,b,
Maria Abad-Fernandez
Maria Abad-Fernandez
aUNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
cDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
a,c,
Marina Tuyishime
Marina Tuyishime
eDepartment of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA
e,
Justin J Pollara
Justin J Pollara
eDepartment of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA
e,
Guido Ferrari
Guido Ferrari
eDepartment of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA
e,
Natalia Soriano-Sarabia
Natalia Soriano-Sarabia
aUNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
bDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
a,b,
David M Margolis
David M Margolis
aUNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
bDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
cDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
dDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
a,b,c,d,✉
aUNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
bDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
cDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
dDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
eDepartment of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA
✉
Address correspondence to David M. Margolis, dmargo@med.unc.edu.
Citation Garrido C, Abad-Fernandez M, Tuyishime M, Pollara JJ, Ferrari G, Soriano-Sarabia N, Margolis DM. 2020. Correction for Garrido et al., “Interleukin-15-stimulated natural killer cells clear HIV-1-infected cells following latency reversal ex vivo.” J Virol 94:e00223-20. https://doi.org/10.1128/JVI.00223-20.
Collection date 2020 Jun.
PDF (149.9 KB)
